Seeking Alpha

Takeda Pharmaceutical (TKPHF.PK) agrees to buy closely-held Swiss rival Nycomed for €9.6B...

Takeda Pharmaceutical (TKPHF.PK) agrees to buy closely-held Swiss rival Nycomed for €9.6B ($13.7B) in a move that will extend Takeda's reach into emerging markets. The price tag, which is slightly larger than had been expected, includes €3.6B of net debt.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs